Atai
0
0
The clinical-stage biopharmaceutical company said it has enough cash to reach the milestones it laid out for 2025. New York-based Atai Life Sciences ...
reviewer4you.com
0
0
New York-based Atai Life Sciences (Nasdaq: ATAI) reported a net loss of $26.3 million for the third quarter, down year-over-year from its net income of ...